The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity
Open accessAbstract
Spontaneously developed germinal centers (GCs [Spt-GCs]) harbor autoreactive B cells that generate somatically mutated and class-switched pathogenic autoantibodies (auto-Abs) to promote autoimmunity. However, the mechanisms that regulate Spt-GC development are not clear. In this study, we report that B cell–intrinsic IFN-γ receptor (IFN-γR) and STAT1 signaling are required for Spt-GC and follicular T helper cell (Tfh cell) development. We further demonstrate that IFN-γR and STAT1 signaling control Spt-GC and Tfh cell formation by driving T-bet expression and IFN-γ production by B cells. Global or B cell–specific IFN-γR deficiency in autoimmune B6.Sle1b mice leads to significantly reduced Spt-GC and Tfh cell responses, resulting in diminished antinuclear Ab reactivity and IgG2c and IgG2b auto-Ab titers compared with B6.Sle1b mice. Additionally, we observed that the proliferation and differentiation of DNA-reactive B cells into a GC B cell phenotype require B cell–intrinsic IFN-γR signaling, suggesting that IFN-γR signaling regulates GC B cell tolerance to nuclear self-antigens. The IFN-γR deficiency, however, does not affect GC, Tfh cell, or Ab responses against T cell–dependent foreign antigens, indicating that IFN-γR signaling regulates autoimmune, but not the foreign antigen–driven, GC and Tfh cell responses. Together, our data define a novel B cell–intrinsic IFN-γR signaling pathway specific to Spt-GC development and autoimmunity. This novel pathway can be targeted for future pharmacological intervention to treat systemic lupus erythematosus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rubtsova, K., Rubtsov, A. V., van Dyk, L. F., Kappler, J. W., & Marrack, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312348110 · Cited by 300
Age-Associated B Cells: A T-bet–Dependent Effector with Roles in Protective and Pathogenic Immunity
Rubtsova, K., Rubtsov, A. V., Cancro, M. P., & Marrack, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501209 · Cited by 246 · cited 1×
“A combination of BCR, TLR7, and IFN-γR signaling has been proposed to drive T-bet expression, which was shown to drive the expression of a recently described age-associated B cell phenotype and class switching to IgG2a and IgG2c Abs (Rubtsov et al., 2013; Rubtsova et al., 2013, 2015).”
BackgroundCritical role for Stat3 in T-dependent terminal differentiation of IgG B cells
Fornek, J. L., Tygrett, L. T., Waldschmidt, T. J., Poli, V., Rickert, R. C., & Kansas, G. S. (2006) · Blood · doi:10.1182/blood-2005-07-2871 · Cited by 148 · cited 1×
“Although the role of STAT1 and STAT3 signaling in B cell activation has recently been described in both mouse and human studies (Su et al., 1999; Xu and Zhang, 2005; Fornek et al., 2006; Avery et al., 2010), the role of STAT1 and/or STAT3 in IFN-γR–mediated Spt-GC development is not clear.”
Background
Cited by
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Cancro, M. P. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-092419-031130 · Cited by 464
Toll-like receptor signalling in B cells during systemic lupus erythematosus
Fillatreau, S., Manfroi, B., & Dörner, T. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00544-4 · Cited by 322
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
van Langelaar, J., Rijvers, L., Smolders, J., & van Luijn, M. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00760 · Cited by 319
Altered B cell signalling in autoimmunity
Rawlings, D. J., Metzler, G., Wray-Dutra, M., & Jackson, S. W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.24 · Cited by 308
Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
Verstappen, G. M., Pringle, S., Bootsma, H., & Kroese, F. G. M. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00605-2 · Cited by 298
B cells expressing the transcription factor T-bet drive lupus-like autoimmunity
Rubtsova, K., Rubtsov, A. V., Thurman, J. M., Mennona, J. M., Kappler, J. W., & Marrack, P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91250 · Cited by 277
B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
Arkatkar, T., Du, S. W., Jacobs, H. M., Dam, E. M., Hou, B., Buckner, J. H., Rawlings, D. J., & Jackson, S. W. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170580 · Cited by 267
Zumaquero, E., Stone, S. L., Scharer, C. D., Jenks, S. A., Nellore, A., Mousseau, B., Rosal-Vela, A., Botta, D., Bradley, J. E., Wojciechowski, W., et al. (2019) · eLife · doi:10.7554/elife.41641 · Cited by 189
Jang (2019) · doi:10.1038/s12276-019-0352-x · Cited by 114
Popescu, M., Cabrera-Martinez, B., & Winslow, G. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900484 · Cited by 72
Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models
Zhan, J., Kipp, M., Han, W., & Kaddatz, H. (2021) · Immunology · doi:10.1111/imm.13395 · Cited by 49
Selective emergence of antibody-secreting cells in the multiple sclerosis brain
Bogers, L., Engelenburg, H. J., Janssen, M., Unger, P.-P. A., Melief, M.-J., Wierenga-Wolf, A. F., Hsiao, C.-C., Mason, M. R. J., Hamann, J., van Langelaar, J., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104465 · Cited by 40
Metadata
- Authors
- Domeier, P. P., Chodisetti, S. B., Soni, C., Schell, S. L., Elias, M. J., Wong, E. B., Cooper, T. K., Kitamura, D., & Rahman, Z. S. M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-04-11
- Volume
- 213
- Issue
- 5
- Pages
- 715-732
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2323307238
- Cited by
- 200
- References
- 3
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.